![]() |
![]() ![]() ![]() ![]() ![]() ![]() |
|
![]() |
![]() The .pfizer Dot BrandPfizer Inc. is a leading global pharmaceutical corporation serving the needs of consumers around the globe. The company has more than 110,000 employees who work in 46 countries. Pfizer products are generally only available on prescription from pharmacies. Pfizer also offers a range of products for the care of animals and livestock. The future mission and purpose of the .pfizer extension is for it to become a "trusted, hierarchical, and intuitive namespace". It will be a trusted source of information for consumers (who may be seeking health advice), medical professionals, investors, the media and the general public. The issue of trust is a paramount concern. The TLD will provide a virtual avenue that will deepen and broaden Pfizer's customer relationships and interaction. It will be a new and innovative channel to increase interest in Pfizer goods & services, ad campaigns, public interest content and awareness initiatives etc. It will help to differentiate the company's offerings in the online space.
The new TLD will provide the company with an unlimited number of intuitive, short and memorable domain names which will help to meet the increasing demands of consumers for new channels on new devices. It will increase consumer recognition of the company's goods & services. Pfizer hopes that ultimately the string will attain the same level of trust that is currently enjoyed by the .edu and .gov gTLDs. Pfizer has a four stage roll-out plan for its brand TLD: 1. A limited number of .pfizer domains will be registered to enable initial planning and operational & security testing etc by personnel. 2. Widespread internal corporate use of the string. Potential strategies to migrate content over to the new TLD will be evaluated. The possibility of extending registration rights to licensees and other partners will come under initial consideration. 3. At this stage content may be permanently migrated over to the new .pfizer TLD, depending on an assessment of Stage 2. The timeline will depend upon "business, strategic, and industry factors at the time". Registration rights may be extended to partners at this point. 4. Based on an ongoing evaluation of previous stages, and taking into consideration changes in the domain name system and in particular the general impact of the other brand domains, the company will continue its implementation of the new string. Pfizer believes it will take at least five years to fully assess the impact of the new TLD program and plan its future expansion.
The company anticipates that the total number of registrations will be less than 10,000 in the first five years of operation. Pfizer intends to closely monitor and analyse the general success of the new gTLD program and in particular the implementation of the brand domains. It is very aware that its new TLD has great potential to play an important online strategic role. The Applicant makes note that at the time of filing, there had not been enough time and available market information to comprehensively evaluate all potential best-in-class case use options. Hence, Pfizer will proceed cautiously since factors such as consumer recognition and the response of search engines are currently unknown.
If the .pfizer string roll-out proceeds in accord with the company's strategic goals, then .pfizer domains will become primary addresses. The TLD has real potential to serve as a cornerstone of Pfizer's strategy to leverage emerging technologies and distribution channels to communicate its offerings. Ultimately it has the potential to provide a valuable, unified, trusted ecosystem experience. If a complete launch unfolds, Pfizer will use various ad, media, outreach and email campaigns to communicate with the public and medical professionals etc. The existing Pfizer.com website has provided a trustworthy platform for information about the company's offerings and their safety since 1992. (Specialist information is also available to medical professionals with approved accounts.)
Pfizer and its back-end registry services provider Neustar, Inc. will work in the public interest to act as responsible stewards of the .pfizer string. The company will implement robust security policies to prevent the online sale or distribution of illegal pharmaceuticals. Privacy and confidentiality will be protected. Intellectual property will also be protected. These policies will also serve to combat any possible abusive or malicious activities such as fraud, phishing, pharming, spam, piracy, cybersquatting, malware distribution, fast flux hosting, botnets and so on. Further, Neustar is experienced in working with law enforcement agencies in this regard. Pfizer points out that its brand TLD will be a single applicant registry a foundation stone that will create a trusted online environment for consumers.
|
![]() |
|
![]() |
![]() |
![]() |
----- ----- ----- ----- -----
Alarm Media THE BRAND DOMAINS
IS PART OF THE ALARM MEDIA ENTERTAINMENT & BUSINESS NETWORK PREMIUM
BUSINESS DOMAIN NAMES FOR SALE FROM THE NETWORK © 2013-14 David Tyrer All rights reserved Website by Click as a Flash Terms and Conditions
|
||
![]() |
![]() |